Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-16

Clinical Trial Update: Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing the Quantiferon-TB Gold assay with tuberculin skin testing in patients with chronic liver disease, including liver transplantatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Liver Disease, Liver Transplantation | Phase 4 | Status: COMPLETED